Stockreport

Immunic sets stage for phase 3 MS data readout after $400M financing [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF Immunic Inc (NASDAQ:IMUX) said it is entering a pivotal period for its multiple sclerosis program after securing up to $400 million in new financing and advancing its l [Read more]